Skip to main content
Erschienen in: Current Infectious Disease Reports 5/2011

01.10.2011

Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock

verfasst von: John D. Dickinson, Marin H. Kollef

Erschienen in: Current Infectious Disease Reports | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Severe sepsis and septic shock are conditions that pose difficult challenges to physicians and the health care system. In the past 10 years, a number of retrospective and prospective observational studies have shed light on the importance of a rapid and systematic approach to treatment of these conditions. A key component is early and appropriate use of antibiotics. Delay of even 6 h can dramatically increase hospital mortality. In addition, multivariate analyses have demonstrated that inappropriate initial antibiotics lead to worse outcomes. The treating physician can rapidly identify risk factors for initial inappropriate antibiotics at the bedside, such as recent antibiotic therapy or recent hospitalization. Organized antibiotic order sets have been shown to significantly improve timely appropriate antibiotic administration in septic patients. Finally, emerging laboratory data suggest that early in the course of septic shock, the pharmacokinetics of common broad spectrum antibiotics may be significantly altered due to increased volumes of distribution having dosing implications for antibiotics in septic shock.
Literatur
1.
Zurück zum Zitat • Dellinger RP, Zimmerman JL, Vincent JL, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327. A thorough summary of important guidelines in the diagnosis and management of septic shock. PubMedCrossRef • Dellinger RP, Zimmerman JL, Vincent JL, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327. A thorough summary of important guidelines in the diagnosis and management of septic shock. PubMedCrossRef
2.
Zurück zum Zitat Vincent JL, Korkut HA. Defining sepsis. Clin in Chest Med. 2008;29:585–90.CrossRef Vincent JL, Korkut HA. Defining sepsis. Clin in Chest Med. 2008;29:585–90.CrossRef
3.
Zurück zum Zitat Alberti C, Brun-Buisson H, Le Gall R, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–21.PubMedCrossRef Alberti C, Brun-Buisson H, Le Gall R, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–21.PubMedCrossRef
4.
Zurück zum Zitat Vincent JL, Sakr Y, Payen D, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.PubMedCrossRef Vincent JL, Sakr Y, Payen D, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.PubMedCrossRef
5.
Zurück zum Zitat Martin GS, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. NEJM. 2003;348:1546–54.PubMedCrossRef Martin GS, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. NEJM. 2003;348:1546–54.PubMedCrossRef
6.
Zurück zum Zitat Drombrovskiy VY, Sunderram J, Martin AA, Paz HL. Rapid Increase in hospitalization and mortality rates for severe sepsis in the United States. Crit Care Med. 2007;35:1244–50.CrossRef Drombrovskiy VY, Sunderram J, Martin AA, Paz HL. Rapid Increase in hospitalization and mortality rates for severe sepsis in the United States. Crit Care Med. 2007;35:1244–50.CrossRef
7.
8.
Zurück zum Zitat Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit cost of illness and cost effectiveness of therapy. Pharmacoeconomics. 2004;22:793–813.PubMedCrossRef Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit cost of illness and cost effectiveness of therapy. Pharmacoeconomics. 2004;22:793–813.PubMedCrossRef
9.
Zurück zum Zitat Shorr AF, Micek S, Jackson WL, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med. 2007;35:1257–62.PubMedCrossRef Shorr AF, Micek S, Jackson WL, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med. 2007;35:1257–62.PubMedCrossRef
10.
Zurück zum Zitat Oterro RM, Nuygen HB, Rivers E, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130:1579–95.CrossRef Oterro RM, Nuygen HB, Rivers E, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest. 2006;130:1579–95.CrossRef
11.
Zurück zum Zitat Talan DA, Zibulewky J. Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993;22:1733–8.PubMedCrossRef Talan DA, Zibulewky J. Relationship of clinical presentation to time to antibiotics for the emergency department management of suspected bacterial meningitis. Ann Emerg Med. 1993;22:1733–8.PubMedCrossRef
12.
Zurück zum Zitat Lebel MH. Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid. Antibiot Chemother. 1992;45:226–38.PubMed Lebel MH. Adverse outcome of bacterial meningitis due to delayed sterilization of cerebrospinal fluid. Antibiot Chemother. 1992;45:226–38.PubMed
13.
Zurück zum Zitat Miner J, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21:387–92.PubMedCrossRef Miner J, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21:387–92.PubMedCrossRef
14.
Zurück zum Zitat Larché J, Azoulay E, Schlemmer B, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.PubMedCrossRef Larché J, Azoulay E, Schlemmer B, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.PubMedCrossRef
15.
Zurück zum Zitat Kumar A, Roberts D, Cheang M, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.PubMedCrossRef Kumar A, Roberts D, Cheang M, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96.PubMedCrossRef
16.
Zurück zum Zitat •• Kumar A, Ellis P, Chateau D, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237–48. Authors demonstrated that timely infusion and appropriate antibiotics had a profound effect on hospital mortality from severe sepsis and septic shock independent of other co morbid conditions. PubMedCrossRef •• Kumar A, Ellis P, Chateau D, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009;136:1237–48. Authors demonstrated that timely infusion and appropriate antibiotics had a profound effect on hospital mortality from severe sepsis and septic shock independent of other co morbid conditions. PubMedCrossRef
17.
Zurück zum Zitat • Ferrer R, Artigas A, Sirvent JM, et al. Effectiveness of treatments for severe sepsis. Am J Resp Crit Care Med 2009;180:861–66. In a ICU patient cohort after the implementation of the Surviving Sepsis Guidelines, administration of timely appropriate antibiotics and drotrecogin-α were associated with reduced mortality from septic shock. PubMedCrossRef • Ferrer R, Artigas A, Sirvent JM, et al. Effectiveness of treatments for severe sepsis. Am J Resp Crit Care Med 2009;180:861–66. In a ICU patient cohort after the implementation of the Surviving Sepsis Guidelines, administration of timely appropriate antibiotics and drotrecogin-α were associated with reduced mortality from septic shock. PubMedCrossRef
18.
Zurück zum Zitat Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes–proceedings of the HCAP Summit. Clin Infect Dis. 2008;46:S296–334.PubMedCrossRef Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes–proceedings of the HCAP Summit. Clin Infect Dis. 2008;46:S296–334.PubMedCrossRef
19.
Zurück zum Zitat Kollef MH, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections. Chest. 1999;115:462–74.PubMedCrossRef Kollef MH, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections. Chest. 1999;115:462–74.PubMedCrossRef
20.
Zurück zum Zitat Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.PubMedCrossRef Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–55.PubMedCrossRef
21.
Zurück zum Zitat Garnacho-Montero J, Garcia-Garmendia JL, Oritz-Leyba C, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–51.PubMedCrossRef Garnacho-Montero J, Garcia-Garmendia JL, Oritz-Leyba C, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–51.PubMedCrossRef
22.
Zurück zum Zitat Friedman ND, Kayes KS, Sexton DJ, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7.PubMed Friedman ND, Kayes KS, Sexton DJ, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–7.PubMed
23.
Zurück zum Zitat Niederman MS, Craven DE. ATS Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med. 2005;171:388–416.CrossRef Niederman MS, Craven DE. ATS Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med. 2005;171:388–416.CrossRef
24.
Zurück zum Zitat •• Micek S, Welch E, Kollef MH, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: A retrospective analysis. Antimicrob Agents Chemother 2010;54:1742–48. A single center study of serious Gram negative blood stream infections demonstrated initial combination antibiotics decreased the risk of receiving inappropriate antibiotics. A higher mortality and increased hospital length of stay for those receiving inappropriate antibiotics. PubMedCrossRef •• Micek S, Welch E, Kollef MH, et al. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: A retrospective analysis. Antimicrob Agents Chemother 2010;54:1742–48. A single center study of serious Gram negative blood stream infections demonstrated initial combination antibiotics decreased the risk of receiving inappropriate antibiotics. A higher mortality and increased hospital length of stay for those receiving inappropriate antibiotics. PubMedCrossRef
25.
Zurück zum Zitat Heyland D, Dodek P, Cook K, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Car Med. 2008;36:737–44.CrossRef Heyland D, Dodek P, Cook K, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Car Med. 2008;36:737–44.CrossRef
26.
Zurück zum Zitat Beardsley J, Williamson JC, Bowton DL, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130:787–93.PubMedCrossRef Beardsley J, Williamson JC, Bowton DL, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130:787–93.PubMedCrossRef
27.
Zurück zum Zitat Dejace P, Klastersky J. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med. 1986;80:29–38.PubMedCrossRef Dejace P, Klastersky J. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med. 1986;80:29–38.PubMedCrossRef
28.
Zurück zum Zitat Bodey GP. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M.D. Anderson Hospital. Review Infect Dis. 1989;11:S1582–90.CrossRef Bodey GP. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M.D. Anderson Hospital. Review Infect Dis. 1989;11:S1582–90.CrossRef
29.
Zurück zum Zitat •• Kumar A, Zarychanski R, Doucette S, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Chest 2010;38:1773–85. This study demonstrated that initial combination antibiotics for septic shock increased 28-day survival (P = 0.0002) along with pressor free and ventilator free days in the ICU. •• Kumar A, Zarychanski R, Doucette S, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Chest 2010;38:1773–85. This study demonstrated that initial combination antibiotics for septic shock increased 28-day survival (P = 0.0002) along with pressor free and ventilator free days in the ICU.
30.
Zurück zum Zitat • Mical P, Simona G, Leibovici L, et al. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Sys Rev 2006;25:CD003344. A large meta-analysis of over 7000 patients with sepsis, pneumonia, endocarditis, and other clinical conditions revealed no benefit to initial combination antibiotics compared to monotherapy. • Mical P, Simona G, Leibovici L, et al. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Sys Rev 2006;25:CD003344. A large meta-analysis of over 7000 patients with sepsis, pneumonia, endocarditis, and other clinical conditions revealed no benefit to initial combination antibiotics compared to monotherapy.
31.
Zurück zum Zitat Hamm C, Goldmann B, Meinertz T, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. NEJM. 1997;337(23):1648–53.PubMedCrossRef Hamm C, Goldmann B, Meinertz T, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. NEJM. 1997;337(23):1648–53.PubMedCrossRef
32.
Zurück zum Zitat Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016–30.PubMed Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016–30.PubMed
33.
Zurück zum Zitat Rivers E, Nguyen B, Peterson E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEJM. 2001;345:1368–77.PubMedCrossRef Rivers E, Nguyen B, Peterson E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEJM. 2001;345:1368–77.PubMedCrossRef
34.
Zurück zum Zitat Micek S, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Car Med. 2006;34:2707–13.CrossRef Micek S, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Car Med. 2006;34:2707–13.CrossRef
35.
Zurück zum Zitat •• Levy MM, Dellinger RP, Regen S, et al. The surviving Sepsis Campaign: results of an international guideline based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31. This large study of patients with severe sepsis compared outcomes after the initiating The Surviving Sepsis Guidelines. PubMedCrossRef •• Levy MM, Dellinger RP, Regen S, et al. The surviving Sepsis Campaign: results of an international guideline based performance improvement program targeting severe sepsis. Intensive Care Med 2010;36:222–31. This large study of patients with severe sepsis compared outcomes after the initiating The Surviving Sepsis Guidelines. PubMedCrossRef
36.
Zurück zum Zitat • Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010;38:668–78. The authors compared multiple studies of the impact of bundled order sets for septic shock. Post-intervention groups had consistent increase in survival and timely, appropriate antibiotic use. PubMedCrossRef • Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010;38:668–78. The authors compared multiple studies of the impact of bundled order sets for septic shock. Post-intervention groups had consistent increase in survival and timely, appropriate antibiotic use. PubMedCrossRef
37.
Zurück zum Zitat Sharma S, Kumar A. Antimicrobial management of sepsis and septic shock. Clin Chest Med. 2008;29:677–87.PubMedCrossRef Sharma S, Kumar A. Antimicrobial management of sepsis and septic shock. Clin Chest Med. 2008;29:677–87.PubMedCrossRef
38.
Zurück zum Zitat • Pea F, Viele P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock—does the dose matter? Crit Care 2009;13:214. An excellent review of the pharmacokinetic and pharmacodynamic changes of antibiotic therapy for severe sepsis and septic shock. PubMedCrossRef • Pea F, Viele P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock—does the dose matter? Crit Care 2009;13:214. An excellent review of the pharmacokinetic and pharmacodynamic changes of antibiotic therapy for severe sepsis and septic shock. PubMedCrossRef
39.
Zurück zum Zitat Rea RS, Capitano B, Smith R, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30:674–81.PubMedCrossRef Rea RS, Capitano B, Smith R, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30:674–81.PubMedCrossRef
40.
Zurück zum Zitat Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29:385–91.PubMedCrossRef Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29:385–91.PubMedCrossRef
41.
Zurück zum Zitat del Mar Fernandez de Gatta Garcia M, Revilla N, Calvo MV, et al. Pharmacokinetic/ pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007;33:279–85. del Mar Fernandez de Gatta Garcia M, Revilla N, Calvo MV, et al. Pharmacokinetic/ pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007;33:279–85.
42.
Zurück zum Zitat Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin. 2011;27:19–34.PubMedCrossRef Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin. 2011;27:19–34.PubMedCrossRef
43.
Zurück zum Zitat Tam VH, McKinnon PS, Akins RL, et al. Pharmacodynamics of cefepime in patients with Gram-negative infections. J AntimicrobChemother. 2002;50:425–8.CrossRef Tam VH, McKinnon PS, Akins RL, et al. Pharmacodynamics of cefepime in patients with Gram-negative infections. J AntimicrobChemother. 2002;50:425–8.CrossRef
44.
Zurück zum Zitat McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. 2008;31:345–51.PubMedCrossRef McKinnon PS, Paladino JA, Schentag JJ. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents. 2008;31:345–51.PubMedCrossRef
45.
Zurück zum Zitat •• Taccone FS, Laterre PF, Vincent JL, et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care Med 2010;14:R126. A prospective study of the pharmacokinetics of 4 common b-lactams administered as first dose antibiotics for septic shock revealed only meropenem reached the target serum MIC for pseudomonas infections. •• Taccone FS, Laterre PF, Vincent JL, et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care Med 2010;14:R126. A prospective study of the pharmacokinetics of 4 common b-lactams administered as first dose antibiotics for septic shock revealed only meropenem reached the target serum MIC for pseudomonas infections.
46.
Zurück zum Zitat Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. 2009;37:2071–8.PubMedCrossRef Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. 2009;37:2071–8.PubMedCrossRef
47.
Zurück zum Zitat Harbarth S, Garbino J, Lew D, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–35.PubMedCrossRef Harbarth S, Garbino J, Lew D, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529–35.PubMedCrossRef
48.
Zurück zum Zitat Zaragoza R, Artero A, Camarena J, et al. The influence of inadequate empirical antimicrobial treatment on patient with blood stream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.PubMedCrossRef Zaragoza R, Artero A, Camarena J, et al. The influence of inadequate empirical antimicrobial treatment on patient with blood stream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412–8.PubMedCrossRef
49.
Zurück zum Zitat Leone M, Bourgoin A, Martin C, et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462–7.PubMedCrossRef Leone M, Bourgoin A, Martin C, et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;31:462–7.PubMedCrossRef
50.
Zurück zum Zitat Shorr AF, Micek S, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39:46–51.PubMedCrossRef Shorr AF, Micek S, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011;39:46–51.PubMedCrossRef
Metadaten
Titel
Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock
verfasst von
John D. Dickinson
Marin H. Kollef
Publikationsdatum
01.10.2011
Verlag
Current Science Inc.
Erschienen in
Current Infectious Disease Reports / Ausgabe 5/2011
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-011-0206-8

Weitere Artikel der Ausgabe 5/2011

Current Infectious Disease Reports 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.